Prognostic value of preoperative fibrinogen in metastatic clear cell renal cell carcinoma patients undergoing cytoreductive nephrectomy: A propensity score-matched study.

被引：0
|
作者：
Shou, Jianzhong
Cui, Honglei
Bi, Xingang
Guan, Youyan
Shi, Hongzhe
Zhou, Aiping
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll Canc, Natl Canc Ctr, Natl Clin Res Ctr Canc, Dept Urol,Canc Hosp, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Canc, Natl Canc Ctr,Canc Hosp, Dept Med Oncol, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
    Fukuda, Hironori
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Shimizu, Satoru
    Nagashima, Yoji
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) : 539 - 546
  • [2] Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
    Hironori Fukuda
    Toshio Takagi
    Tsunenori Kondo
    Kazuhiko Yoshida
    Satoru Shimizu
    Yoji Nagashima
    Kazunari Tanabe
    International Journal of Clinical Oncology, 2018, 23 : 539 - 546
  • [3] PROGNOSTIC VALUE OF THE GLASGOW PROGNOSTIC SCORE FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH CYTOREDUCTIVE NEPHRECTOMY
    Fukuda, Hironori
    Takagi, Toshio
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Shimizu, Satoru
    Nagashima, Yoji
    Tanabe, Kazunari
    JOURNAL OF UROLOGY, 2018, 199 (04): : E490 - E490
  • [4] Cytoreductive nephrectomy in primary metastatic clear cell renal cell carcinoma
    Beisland, Christian
    SCANDINAVIAN JOURNAL OF UROLOGY, 2020, 54 (06) : 500 - 500
  • [5] Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study
    Ishihara, Hiroki
    Kondo, Tsunenori
    Yoshida, Kazuhiko
    Omae, Kenji
    Takagi, Toshio
    Iizuka, Junpei
    Tanabe, Kazunari
    CLINICAL GENITOURINARY CANCER, 2017, 15 (05) : 598 - 604
  • [6] Survival Outcomes Associated With Cytoreductive Nephrectomy in Patients With Metastatic Clear Cell Renal Cell Carcinoma
    Chakiryan, Nicholas H.
    Gore, L. Robert
    Reich, Richard R.
    Dunn, Rodney L.
    Jiang, Da David
    Gillis, Kyle A.
    Green, Elizabeth
    Hajiran, Ali
    Hugar, Lee
    Zemp, Logan
    Zhang, Jingsong
    Jain, Rohit K.
    Chahoud, Jad
    Spiess, Philippe E.
    Manley, Brandon J.
    Sexton, Wade J.
    Hollenbeck, Brent K.
    Gilbert, Scott M.
    JAMA NETWORK OPEN, 2022, 5 (05)
  • [7] Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)
    Aizer, Ayal A.
    Urun, Yuksel
    McKay, Rana R.
    Kibel, Adam S.
    Nguyen, Paul L.
    Choueiri, Toni K.
    BJU INTERNATIONAL, 2014, 113 (5B) : E67 - E74
  • [8] Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score-matched study
    Kishitani, Kenjiro
    Taguchi, Satoru
    Tanaka, Koji
    Danno, Tetsuya
    Oshina, Takahiro
    Fujii, Yoichi
    Kamei, Jun
    Akiyama, Yoshiyuki
    Kakutani, Shigenori
    Sato, Yusuke
    Yamada, Yuta
    Niimi, Aya
    Yamada, Daisuke
    Kume, Haruki
    INTERNATIONAL JOURNAL OF UROLOGY, 2025, 32 (02) : 145 - 150
  • [9] Systemic inflammation response index predicts prognosis in patients with clear cell renal cell carcinoma: a propensity score-matched analysis
    Chen, Zhen
    Wang, Kai
    Lu, Hao
    Xue, Dong
    Fan, Min
    Zhuang, Qianfeng
    Yin, Shuai
    He, Xiaozhou
    Xu, Renfang
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 909 - 919
  • [10] SHOULD PATIENTS WITH METASTATIC NON-CLEAR CELL RENAL CELL CARCINOMA UNDERGO CYTOREDUCTIVE NEPHRECTOMY?
    Keskin, Sarp
    Petros, Firas
    Yu, Kai-jie
    Aboshady, Yara
    Borregales, Leonardo
    Kenney, Patrick
    Matin, Surena
    Karam, Jose
    Wood, Christopher
    JOURNAL OF UROLOGY, 2017, 197 (04): : E65 - E66
12345